See something incorrect? Let us know below.

Jakafi medication site with options to learn about conditions treated: Polycythemia Vera, Myelofibrosis, and Graft-Versus-Host Disease

Incyte Corporation

jakafi.com

Incyte Corporation, a pharmaceutical manufacturing company, provides Jakafi® (ruxolitinib) for treating adults with polycythemia vera, certain types of myelofibrosis, and acute or chronic graft-versus-host disease in patients aged 12 and older who have not responded adequately to prior treatments.

Healthcare

Tranco Rank: #2054299

View Details

Please explain the issue

Website

If this is wrongly classified, we appreciate if you could suggest the right classification

Contact Details (optional, so we can reach you if needed)

Full Name

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Ask

Follow Us